Insertable cardiac monitor detection of silent atrial fibrillation in candidates for percutaneous patent foramen ovale closure

Autor: Marcella Jorfida, Fabrizio D'Ascenzo, Carla Giustetto, Christian Pristipino, Domenica Zema, Paolo Cerrato, Lorenza M Biava, Ilaria Meynet, Paolo Scacciatella, Fiorenzo Gaita
Rok vydání: 2019
Předmět:
Male
Cardiac Catheterization
medicine.medical_specialty
Time Factors
Percutaneous
Deep vein
medicine.medical_treatment
Clinical Decision-Making
Foramen Ovale
Patent

Unnecessary Procedures
030204 cardiovascular system & hematology
Electrocardiography
03 medical and health sciences
0302 clinical medicine
Heart Rate
Predictive Value of Tests
Risk Factors
Internal medicine
Atrial Fibrillation
Humans
Telemetry
Medicine
Prospective Studies
cardiovascular diseases
030212 general & internal medicine
Aged
Cardiac catheterization
business.industry
Patient Selection
Atrial fibrillation
General Medicine
Middle Aged
medicine.disease
Thrombosis
cryptogenic stroke – patent foramen ovale – internal cardiac monitor
Progression-Free Survival
Stroke
Treatment Outcome
medicine.anatomical_structure
Heart failure
Asymptomatic Diseases
cardiovascular system
Foramen ovale closure
Patent foramen ovale
Cardiology
Female
Cardiology and Cardiovascular Medicine
business
Zdroj: Journal of Cardiovascular Medicine. 20:290-296
ISSN: 1558-2027
DOI: 10.2459/jcm.0000000000000790
Popis: Aim An underlying atrial vulnerability or a preexisting misdiagnosed atrial fibrillation in some patients who are candidates for patent foramen ovale (PFO) closure may lead to an unnecessary percutaneous intervention. The aim of this work was to define paroxysmal atrial fibrillation rate, through a 6-month insertable loop-recorder monitoring, in patients over 55 years old with cryptogenic stroke and PFO. Methods PFO closure criteria: significant right-to-left shunt and at least one high-risk feature (permanent right-to-left shunt, atrial septal aneurysm, prominent Eustachian valve, recurrent brain ischemia, previous deep vein thrombosis, thrombophilia). Insertable cardiac monitoring criteria: previous cryptogenic stroke, more than 55 years and at least one atrial fibrillation risk factor (heart failure, hypertension, age older than 65 years, diabetes, atrial runs, left atrium dilatation, left ventricle hypertrophy, pulmonary disease, thyroid disease, obesity). Atrial fibrillation detection threshold: arrhythmia duration longer than 5 min. Results From January 2008 to March 2017, 195 patients underwent to loop-recorder monitoring. A total of 70 (36%) patients were candidates for PFO closure. The 6-month silent atrial fibrillation rate was 11.4%. In the arrhythmia-free cohort, 28 patients (45.2%) underwent percutaneous foramen ovale closure (group A) and 34 (54.8%) were medically treated (group B). Atrial fibrillation detection rate was 14.3% in group A and 0% in group B. The 36-month atrial fibrillation-free survival was 76%. Conclusion An occult preexisting atrial fibrillation may lead to unnecessary percutaneous foramen ovale closure in a significant proportion of patients. A 6-month loop-recorder monitoring may improve the patient oriented decision-making.
Databáze: OpenAIRE